Abatacept for immune checkpoint inhibitor associated myocarditis (ATRIUM): Phase 3, investigator-initiated, randomized, placebo-controlled study to evaluate the efficacy and safety of abatacept ...
LONDON, Sept 29 (Reuters) - The same mechanism that makes Amgen's new bone drug denosumab an effective treatment for osteoporosis may also mean it could help prevent breast cancer, scientists said on ...
A 3-month course of romosozumab followed by denosumab provides similar BMD gains to those seen with 12 months of romosozumab in women with postmenopausal osteoporosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results